-
Mashup Score: 1
Pfizer and BioNTech will be the first developers of a COVID-19 vaccine to dose patients beyond clinical trials in the United States, as the FDA on Friday evening granted the companies an emergency use authorization (EUA) for their messenger RNA (mRNA)-based BNT162b2.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Researchers Offer K-12 Guidance for Reopening Schools - 4 year(s) ago
Includes testing and screening protocols
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 2AstraZeneca Pauses Phase III COVID-19 Vaccine Trial, Citing "Potentially Unexplained Illness" - 4 year(s) ago
AstraZeneca acknowledged that it has paused the up-to-30,000 patient Phase III trial of its closely-watched COVID-19 vaccine candidate AZD1222—which it is co-developing with the University of Oxford and a spinout company—to investigate a “potentially unexplained illness” involving a participant from the U.K.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Health Chief’s Early Missteps Set Back Coronavirus Response — The Wall Street Journal - 4 year(s) ago
Alex Azar, the Health and Human Services secretary, waited for weeks to brief the president, oversold his agency’s progress and didn’t effectively coordinate the health-care divisions under his purview.
Source: apple.newsCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 1The world's biggest smartphone conference was just canceled because of coronavirus concerns - 4 year(s) ago
Mobile World Congress, or MWC, was going to proceed because there were still 2,800 exhibitors. Now it’s being canceled.
Source: Business InsiderCategories: Hem/OncsTweet
.@FDA Grants @pfizer and @BioNTech_Group Emergency Use Authorization for #COVID19 Vaccine. Learn more: https://t.co/GQWUYERXwV #vaccine #SARSCoV2 #coronavius https://t.co/8UvprpuTfN